(0.09%) 5 521.75 points
(0.14%) 39 899 points
(0.17%) 19 784 points
(-0.07%) $81.57
(0.68%) $2.83
(-0.26%) $2 338.20
(0.10%) $29.56
(0.48%) $1 006.60
(0.06%) $0.932
(-0.04%) $10.53
(0.01%) $0.788
(-0.85%) $87.25
0.00% $ 10.50
Live Chart Being Loaded With Signals
Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer...
Stats | |
---|---|
Dzisiejszy wolumen | 63 651 |
Średni wolumen | 233 019 |
Kapitalizacja rynkowa | 0.00 |
EPS | $-0.730 ( Q1 | 2022-05-12 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-3.85 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.291 (2.77%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-05-31 | Powell Michael | Sell | 30 000 | Stock Option (Right to Buy) |
2022-05-31 | Powell Michael | Sell | 10 030 | Stock Option (Right to Buy) |
2022-05-31 | Powell Michael | Sell | 30 000 | Stock Option (Right to Buy) |
2022-05-31 | Flaherty Keith T. | Sell | 10 030 | Stock Option (Right to Buy) |
2022-05-31 | Flaherty Keith T. | Sell | 4 012 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
0.00 |
Last 90 transactions |
Buy: 10 162 192 | Sell: 69 692 426 |
Wolumen Korelacja
Checkmate Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Checkmate Korelacja - Waluta/Towar
Checkmate Finanse
Annual | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-6.42 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-6.42 |
FY | 2020 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-4.49 |
FY | 2019 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-3.44 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Checkmate
Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naïve neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. Checkmate Pharmaceuticals, Inc. has strategic alliances with Merck KGaA and Pfizer. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. As of May 27, 2022, Checkmate Pharmaceuticals, Inc. operates as a subsidiary of Regeneron Pharmaceuticals, Inc.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej